Department of Health
150,000 Australians are diagnosed with cancer every year. Most of them will be treated with drugs developed over 25 years ago, many of which may have severe side effects.
Ternarx will develop new protein degrader technology to create next-generation cancer medicines with greater efficacy and fewer side effects.
Ternarx is a WEHI spinout company funded through a $15 million grant from the MRFF's Frontier Health and Medical Research initiative.
Read the media release
/Media Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
